Kestra Medical Technologies Ltd expected to post a loss of 60 cents a share - Earnings Preview

Reuters

Mar 14

Kestra Medical Technologies Ltd <kmts.oq> expected to post a loss of 60 cents a share - Earnings Preview </kmts.oq>

Kestra Medical Technologies Ltd KMTS.OQ KMTS.O is expected to report resultson March 17 for the period ending January 31 2026
The Kirkland Washington-based company is expected to report revenue of $22.862 million, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for Kestra Medical Technologies Ltd is for a loss of 60 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Kestra Medical Technologies Ltd is $30.00, about 57.7% above its last closing price of $19.02

Previous quarterly performance (using preferred earnings measure in US dollars).

QUARTER ENDING	STARMINESMARTESTIMATE®	LSEG IBES ESTIMATE	ACTUAL	BEAT, MET, MISSED	SURPRISE %
Oct. 31 2025	-0.59	-0.59	-0.64	Missed	-8
Jul. 31 2025	-0.76	-0.76	-0.45	Beat	40.9
Apr. 30 2025	-0.52	-0.52	-2.21	Missed	-321

This summary was machine generated March 13 at 20:54 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2619414827"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2619414827\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2619414827?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-14 04:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619414827","market":"us","top_or_hot":-1,"title":"Kestra Medical Technologies Ltd  expected to post a loss of 60 cents a share - Earnings Preview","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Kestra Medical Technologies Ltd <kmts.oq> expected to post a loss of 60 cents a share - Earnings Preview </kmts.oq></title></head><body><ul><li><p>Kestra Medical Technologies Ltd <span>KMTS.OQ</span> <span>KMTS.O</span> is expected to  report resultson March 17 for the period ending January 31 2026</p></li><li><p>The Kirkland Washington-based  company is expected to report revenue of $22.862 million, according to the mean estimate from 7 analysts, based on LSEG data.</p></li><li><p>LSEG's mean analyst estimate for Kestra Medical Technologies Ltd is for a loss of 60 cents per share. </p></li><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 6 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  </p></li><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>Wall Street's median 12-month price target for Kestra Medical Technologies Ltd is $30.00, about 57.7% above its last closing price of $19.02</p></li></ul><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>STARMINESMARTESTIMATE®</p></td><td><p>LSEG IBES ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td><td><p>SURPRISE %</p></td></tr><tr><td><p>Oct. 31 2025</p></td><td><p>-0.59</p></td><td><p>-0.59</p></td><td><p>-0.64</p></td><td><p>Missed</p></td><td><p>-8</p></td></tr><tr><td><p>Jul. 31 2025</p></td><td><p>-0.76</p></td><td><p>-0.76</p></td><td><p>-0.45</p></td><td><p>Beat</p></td><td><p>40.9</p></td></tr><tr><td><p>Apr. 30 2025</p></td><td><p>-0.52</p></td><td><p>-0.52</p></td><td><p>-2.21</p></td><td><p>Missed</p></td><td><p>-321</p></td></tr><tr><td><p></p></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td><p></p></td></tr></tbody></table><p>This summary was machine generated March 13 at 20:54 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kestra Medical Technologies Ltd  expected to post a loss of 60 cents a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKestra Medical Technologies Ltd  expected to post a loss of 60 cents a share - Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-14 04:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Kestra Medical Technologies Ltd <kmts.oq> expected to post a loss of 60 cents a share - Earnings Preview </kmts.oq></title></head><body><ul><li><p>Kestra Medical Technologies Ltd <span>KMTS.OQ</span> <span>KMTS.O</span> is expected to  report resultson March 17 for the period ending January 31 2026</p></li><li><p>The Kirkland Washington-based  company is expected to report revenue of $22.862 million, according to the mean estimate from 7 analysts, based on LSEG data.</p></li><li><p>LSEG's mean analyst estimate for Kestra Medical Technologies Ltd is for a loss of 60 cents per share. </p></li><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 6 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  </p></li><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>Wall Street's median 12-month price target for Kestra Medical Technologies Ltd is $30.00, about 57.7% above its last closing price of $19.02</p></li></ul><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>STARMINESMARTESTIMATE®</p></td><td><p>LSEG IBES ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td><td><p>SURPRISE %</p></td></tr><tr><td><p>Oct. 31 2025</p></td><td><p>-0.59</p></td><td><p>-0.59</p></td><td><p>-0.64</p></td><td><p>Missed</p></td><td><p>-8</p></td></tr><tr><td><p>Jul. 31 2025</p></td><td><p>-0.76</p></td><td><p>-0.76</p></td><td><p>-0.45</p></td><td><p>Beat</p></td><td><p>40.9</p></td></tr><tr><td><p>Apr. 30 2025</p></td><td><p>-0.52</p></td><td><p>-0.52</p></td><td><p>-2.21</p></td><td><p>Missed</p></td><td><p>-321</p></td></tr><tr><td><p></p></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td><p></p></td></tr></tbody></table><p>This summary was machine generated March 13 at 20:54 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nL8N401235:1","article_id":"2619414827","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2619414827","pubTimestamp":1773435251,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Kestra Medical Technologies Ltd  expected to post a loss of60cents a share - Earnings Preview Kestra Medical Technologies Ltd KMTS.OQ KMTS.O is expected to  report resultson March 17 for the period en","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","KMTS":"Kestra Medical Technologies Inc"},"translate_title":"Kestra Medical Technologies Ltd预计每股亏损60美分-收益预览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KMTS":0.9},"content_text":"Kestra Medical Technologies Ltd  expected to post a loss of 60 cents a share - Earnings Preview Kestra Medical Technologies Ltd KMTS.OQ KMTS.O is expected to  report resultson March 17 for the period ending January 31 2026The Kirkland Washington-based  company is expected to report revenue of $22.862 million, according to the mean estimate from 7 analysts, based on LSEG data.LSEG's mean analyst estimate for Kestra Medical Technologies Ltd is for a loss of 60 cents per share. The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 6 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Kestra Medical Technologies Ltd is $30.00, about 57.7% above its last closing price of $19.02Previous quarterly performance (using preferred earnings measure in US dollars). QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATE ACTUALBEAT, MET, MISSEDSURPRISE %Oct. 31 2025-0.59-0.59-0.64Missed-8Jul. 31 2025-0.76-0.76-0.45Beat40.9Apr. 30 2025-0.52-0.52-2.21Missed-321This summary was machine generated March 13 at 20:54 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,preview","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}